surmount 1 tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial SURMOUNT-1: Tirzepatide Drastically Reduces Weight – SURMOUNT-1 Trial Summary: What Tirzepatide

Polycystic ovarian syndrome (PCOS) is a condition that likely has a large blood sugar component

SGLT2 inhibitors are a welcome addition to the treatment options as, currently, only loop diuretics to relieve fluid overload are advised as a pharmacological intervention in HFpEF (other than general measures to reduce risk factors antiplatelet, statin, antihypertensive medications

It is not contraindicated to use if youve had a history of pancreatitis, however, we will continue to monitor your tolerance and symptoms closely

Your Guide for Best Results Inject once per week on the same day, as directed by your prescribing provider

The gradual escalation protocol exists to minimize nausea and gastrointestinal side effects while allowing your body to adapt to medication

Specifically, the peptide will interact with MC3R and MC4R